SEC Form 4 · accession 0001209191-16-128786
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Ward Wolff
Director
Period of report
Jun 17, 2016
Accepted (ET)
Jun 20, 2016 · 3:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 17, 2016 | A | 3,000 | $0.00 | A | 3,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $24.19 | Jun 17, 2016 | A | 6,000 | A | — | Jun 17, 2026 | Common Stock | 6,000 | 6,000 | D |
Explanation of responses
- F1Grant of Restricted Stock Units ("RSU") in consideration of services rendered. The RSUs fully vest on March 1, 2017, subject to Reporting Person's Continuous Service as of each such date.
- F2The option shares shall vest as follows: 1/12th of the shares subject to such option shall vest each month after June 1, 2016, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date.